{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:53:44Z","timestamp":1772632424969,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrent pulmonary tuberculosis (PTB) after successful treatment is a significant challenge for current TB control efforts. This study investigated the epidemiological characteristics of recurrent PTB in western Zhejiang Province, aiming to identify risk factors for recurrence and predictors of retreatment outcomes, thereby providing a scientific basis for targeted prevention and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study utilized surveillance data from the Tuberculosis Information Management System in Quzhou, Zhejiang, from January 1, 2007, to December 31, 2024. Recurrence-free intervals were analyzed to identify temporal patterns, and multivariable Cox proportional hazards regression models were employed to determine independent risk factors for recurrence and adverse retreatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 28,458 patients, 897 (3.15%) experienced recurrence. These cases were predominantly male (79.2%), older (mean age, 61.6\u202fyears), and farmers (80.3%). Recurrence-free intervals significantly shortened with subsequent episodes, dropping from a median of 804\u202fdays (95% CI, 740\u2013900) for the first recurrence to 495\u202fdays (95% CI, 394\u2013737) for the second (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Nearly half (48.9%) of all recurrences occurred within the first 2\u202fyears after treatment. Independent predictors of recurrence included advanced age (Adjusted HR, 1.77 for \u226565\u202fyears [95% CI, 1.46\u20132.16]), male sex (AHR, 1.42 [95% CI, 1.21\u20131.67]), and farming occupation (AHR, 1.22 [95% CI, 1.02\u20131.46]). For retreatment outcomes, age \u226565\u202fyears was the independent risk factor for adverse events (AHR, 1.91 [95% CI, 1.07\u20133.40]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nearly half of the recurrences occurred within 2\u202fyears after treatment completion, and recurrence-free intervals progressively shortened with repeated episodes. The older population (\u226565\u202fyears) faced a dual burden, identified as the primary risk group for both recurrence and adverse retreatment outcomes. For the risk factors of recurrence and the success of treatment, it is necessary to further refine and explore the influencing factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1777279","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:01:30Z","timestamp":1772607690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological analysis and risk factors of recurrent pulmonary tuberculosis in Western Zhejiang Province, China (2007\u20132024)"],"prefix":"10.3389","volume":"14","author":[{"given":"Yide","family":"Hu","sequence":"first","affiliation":[{"name":"School of Public Health, Zhejiang Chinese Medicine University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Quzhou Centre for Disease Control and Prevention","place":["Quzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[{"name":"Quzhou Centre for Disease Control and Prevention","place":["Quzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Hao","sequence":"additional","affiliation":[{"name":"Quzhou Centre for Disease Control and Prevention","place":["Quzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Quzhou Centre for Disease Control and Prevention","place":["Quzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Center for Disease Control and Prevention","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingdong","family":"Zhan","sequence":"additional","affiliation":[{"name":"School of Public Health, Zhejiang Chinese Medicine University","place":["Hangzhou, Zhejiang, China"]},{"name":"Quzhou Centre for Disease Control and Prevention","place":["Quzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"857598","DOI":"10.1155\/2015\/857598","article-title":"Mycobacterium tuberculosis","volume":"2015","author":"Venketaraman","year":"2015","journal-title":"J Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1164\/rccm.201601-0129UP","article-title":"Update in tuberculosis\/pulmonary infections 2015","volume":"194","author":"Koenig","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/s0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0082924","DOI":"10.1128\/spectrum.00829-24","article-title":"The Hnrnp A2b1 is important for the replication of Sftsv and other Rna viruses","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol Spectrum"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12889-015-2195-2","article-title":"Tuberculosis retreatment 'others' in comparison with classical retreatment cases; a retrospective cohort review","volume":"15","author":"Nabukenya-Mudiope","year":"2015","journal-title":"BMC Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1115295","DOI":"10.3389\/fmicb.2023.1115295","article-title":"Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: a retrospective study revealed by whole genome sequencing","volume":"14","author":"He","year":"2023","journal-title":"Front Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1183\/09031936.00104108","article-title":"Recurrence of tuberculosis in a low-incidence setting","volume":"33","author":"Dobler","year":"2009","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"eaba4901","DOI":"10.1126\/sciadv.aba4901","article-title":"Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments","volume":"6","author":"Liu","year":"2020","journal-title":"Sci Adv"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijid.2021.07.057","article-title":"Tuberculosis recurrence over a 7-year follow-up period in successfully treated patients in a routine program setting in China: a prospective longitudinal study","volume":"110","author":"Lin","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/jech.2008.077560","article-title":"Tuberculosis recurrence and its associated risk factors among successfully treated patients","volume":"63","author":"Millet","year":"2009","journal-title":"J Epidemiol Community Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu16040558","article-title":"Vitamin D status, Vdr, and Tlr polymorphisms and pulmonary tuberculosis epidemiology in Kazakhstan","volume":"16","author":"Yerezhepov","year":"2024","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1340673","DOI":"10.3389\/fpubh.2024.1340673","article-title":"Pulmonary tuberculosis epidemiology and genetics in Kazakhstan","volume":"12","author":"Yerezhepov","year":"2024","journal-title":"Front Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","article-title":"Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study","volume":"17","author":"Hm","year":"2022","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40249-016-0104-2","article-title":"Spatial and temporal analysis of tuberculosis in Zhejiang Province, China, 2009-2012","volume":"5","author":"E","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijid.2021.07.057","article-title":"Tuberculosis recurrence over a 7-year follow-up period in successfully treated patients in a routine program setting in China: A prospective longitudinal study","volume":"110","author":"Lin","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/ijmm.2022.5174","article-title":"Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (review)","volume":"50","author":"T","year":"2022","journal-title":"Int J Mol Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4314\/ahs.v23i3.43","article-title":"Epidemiological features of tuberculosis in the Middle East and North Africa from 1990 to 2019: results from the global burden of disease study 2019","volume":"23","author":"Moradinazar","year":"2023","journal-title":"Afr Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e2427266","DOI":"10.1001\/jamanetworkopen.2024.27266","article-title":"Recurrent pulmonary tuberculosis in China, 2005 to 2021","volume":"7","author":"T","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0215855","DOI":"10.1371\/journal.pone.0215855","article-title":"Poor outcomes in recurrent tuberculosis: more than just drug resistance?","volume":"14","author":"Cohen","year":"2019","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cmi.2021.09.022","article-title":"Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China","volume":"28","author":"Ruan","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijmy.ijmy_164_17","article-title":"Patients at high risk of tuberculosis recurrence","volume":"7","author":"M","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"ref23","first-page":"237","article-title":"Risk factors for recurrent tuberculosis among successfully treated patients in Israel, 1999-2011","volume":"19","author":"Zhdanov","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12879-017-2933-4","article-title":"A nested case-control study of predictors for tuberculosis recurrence in a large UK centre","volume":"18","author":"Rosser","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.5588\/ijtld.10.0448","article-title":"Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting","volume":"15","author":"Pettit","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2022.27.12.2100183","article-title":"Recurrent tuberculosis in the Netherlands - a 24-year follow-up study, 1993 to 2016","volume":"27","author":"Erkens","year":"2022","journal-title":"Euro Surveill"},{"key":"ref27","first-page":"828","article-title":"Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk","volume":"11","author":"Panjabi","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/ftubr.2024.1433975","article-title":"Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohorts","volume":"2","author":"Krishnan","year":"2024","journal-title":"Front Tuberc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.ijmyco.2016.08.017","article-title":"Identifying patients at high risk of tuberculosis recurrence","volume":"5","author":"Sadikot","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/thx.2009.124677","article-title":"Risk factors for recurrent tuberculosis in England and Wales, 1998-2005","volume":"65","author":"Crofts","year":"2010","journal-title":"Thorax"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e64898","DOI":"10.1371\/journal.pone.0064898","article-title":"Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?","volume":"8","author":"Millet","year":"2013","journal-title":"PLoS One"},{"key":"ref32","first-page":"638990","article-title":"Relapse or re-infection, the situation of recurrent tuberculosis in eastern China","volume-title":"Front Cell Infect Microbiol","author":"Shao","year":"2021"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e0200150","DOI":"10.1371\/journal.pone.0200150","article-title":"Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the revised National Tuberculosis Control Programme, India: a multi-centric prospective study","volume":"13","author":"Velayutham","year":"2018","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12879-020-05515-4","article-title":"Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study","volume":"20","author":"Cudahy","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cid\/ciu186","article-title":"The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study","volume":"58","author":"Marx","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jiph.2023.09.005","article-title":"The incidence of tuberculosis recurrence: impacts of treatment duration of and adherence to standard anti-tuberculous therapy","volume":"16","author":"Lee","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/23744235.2024.2313668","article-title":"Cd8 + T cell response in Quantiferon-Tb gold plus testing was associated with tuberculosis recurrence: a 2-year prospective study","volume":"56","author":"Xin","year":"2024","journal-title":"Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5588\/ijtld.17.0590","article-title":"Recurrent tuberculosis in the pre-elimination era","volume":"22","author":"Rosser","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0970-2113.95320","article-title":"Dots for Tb relapse in India: a systematic review","volume":"29","author":"Azhar","year":"2012","journal-title":"Lung India"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.annepidem.2005.03.002","article-title":"Why pulmonary tuberculosis recurs: a population-based epidemiological study","volume":"15","author":"Pozsik","year":"2005","journal-title":"Ann Epidemiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.4269\/ajtmh.16-0251","article-title":"Epidemiological and clinical features of severe fever with thrombocytopenia syndrome during an outbreak in South Korea, 2013-2015","volume":"95","author":"Park","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref42","first-page":"450","article-title":"Analysis of factors affecting the epidemiology of tuberculosis in China","volume":"9","author":"Liu","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/s0140-6736(19)31882-3","article-title":"Management of drug-resistant tuberculosis","volume":"394","author":"Lange","year":"2019","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0193396","DOI":"10.1371\/journal.pone.0193396","article-title":"Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: a ten-year retrospective cohort study","volume":"13","author":"Dangisso","year":"2018","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/inf.0000000000003922","article-title":"Recurrent tuberculosis treatment episodes in children presenting with presumptive pulmonary tuberculosis in Cape Town, South Africa","volume":"42","author":"Mckenzie","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e0011968","DOI":"10.1371\/journal.pntd.0011968","article-title":"Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National Tb dataset","volume":"18","author":"Njiro","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.4103\/jfmpc.jfmpc_415_20","article-title":"Awareness about tuberculosis and Rntcp services among rural people in Nalgonda district, Telangana","volume":"9","author":"Jothula","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1016\/s2352-3018(15)00200-3","article-title":"Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (chips): a cohort study","volume":"2","author":"Turkova","year":"2015","journal-title":"Lancet HIV"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pneumo.2011.10.001","article-title":"Treatment of recurrent pulmonary tuberculosis","volume":"68","author":"Racil","year":"2012","journal-title":"Rev Pneumol Clin"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1183\/09031936.00114214","article-title":"Smoking adversely affects treatment response, outcome and relapse in tuberculosis","volume":"45","author":"Leung","year":"2015","journal-title":"Eur Respir J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e0215855","DOI":"10.1371\/journal.pone.0215855","article-title":"Poor outcomes in recurrent tuberculosis: more than just drug resistance?","volume":"14","author":"Cohen","year":"2019","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/23744235.2020.1794027","article-title":"Tuberculosis relapse is more common than reinfection in Beijing, China","volume":"52","author":"Liu","year":"2020","journal-title":"Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002281","article-title":"Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and Meta-analysis","volume":"11","author":"Vega","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/cid\/cis1008","article-title":"Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence","volume":"56","author":"Franke","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1777279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:01:31Z","timestamp":1772607691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1777279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":54,"alternative-id":["10.3389\/fpubh.2026.1777279"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1777279","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1777279"}}